Stockscreener 앱 받기
25.13
0.36%
-0.09
전일 마감가:
$25.22
열려 있는:
$25.32
하루 거래량:
174.63K
Relative Volume:
0.93
시가총액:
$1.11B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+10.36%
1개월 성능:
+31.57%
6개월 성능:
+70.26%
1년 성능:
+0.00%
1일 변동 폭
$24.48
$25.88
1주일 범위
$20.95
$25.88
52주 변동 폭
$7.255
$25.88
Sionna Therapeutics Inc Stock (SION) Company Profile
명칭
Sionna Therapeutics Inc
전화
617-819-2020
주소
21 HICKORY DRIVE, SUITE 500, WALTHAM
SION을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SION
Sionna Therapeutics Inc
|
25.13 | 1.11B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Sionna Therapeutics Inc Stock (SION) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-04 | 개시 | Guggenheim | Buy |
| 2025-03-04 | 개시 | Stifel | Buy |
| 2025-03-04 | 개시 | TD Cowen | Buy |
Sionna Therapeutics Inc 주식(SION)의 최신 뉴스
Real time scanner hits for Sionna Therapeutics Inc. explainedQuarterly Investment Review & AI Enhanced Execution Alerts - Newser
What the charts say about Sionna Therapeutics Inc. todayQuarterly Trade Report & Weekly Momentum Picks - Newser
How moving averages guide Sionna Therapeutics Inc. tradingQuarterly Portfolio Summary & AI Based Buy and Sell Signals - Newser
Will Sionna Therapeutics Inc. outperform the marketJuly 2025 PreEarnings & Risk Controlled Daily Trade Plans - Newser
Combining price and volume data for Sionna Therapeutics Inc.2025 Sector Review & Daily Chart Pattern Signal Reports - Newser
Real time pattern detection on Sionna Therapeutics Inc. stockPortfolio Update Report & Fast Momentum Stock Entry Tips - Newser
Sionna Therapeutics Inc. recovery potential after sell offJuly 2025 Patterns & Stock Market Timing Techniques - Newser
What institutional flow reveals about Sionna Therapeutics Inc.July 2025 Recap & Fast Gain Swing Alerts - Newser
Detecting support and resistance levels for Sionna Therapeutics Inc.Earnings Overview Summary & AI Driven Price Predictions - Newser
Using data filters to optimize entry into Sionna Therapeutics Inc.Weekly Trade Summary & AI Enhanced Trading Signals - Newser
Will Sionna Therapeutics Inc. price bounce be sustainable2025 Price Targets & Free Real-Time Volume Trigger Notifications - Newser
Custom strategy builders for tracking Sionna Therapeutics Inc.July 2025 Trade Ideas & Daily Market Momentum Tracking - Newser
Sionna Therapeutics Inc. stock outlook for YEAR2025 Earnings Surprises & Fast Moving Market Watchlists - Newser
Can Sionna Therapeutics Inc. recover in the next quarterJuly 2025 Patterns & Fast Exit and Entry Strategy Plans - Newser
Real time social sentiment graph for Sionna Therapeutics Inc.July 2025 Price Swings & Accurate Intraday Trading Signals - Newser
Why Sionna Therapeutics Inc. stock attracts strong analyst attentionJuly 2025 Reactions & High Yield Stock Recommendations - Newser
Comparing Sionna Therapeutics Inc. in custom built stock radarsWeekly Risk Summary & Safe Capital Growth Stock Tips - Newser
Why Sionna Therapeutics Inc. is moving todayQuarterly Investment Review & Weekly Hot Stock Watchlists - Newser
How to use a screener to detect Sionna Therapeutics Inc. breakoutsRate Hike & Technical Confirmation Trade Alerts - Newser
How to track smart money flows in Sionna Therapeutics Inc.Analyst Upgrade & Daily Oversold Stock Bounce Ideas - Newser
Quantitative breakdown of Sionna Therapeutics Inc. recent moveTrade Entry Report & Weekly Setup with ROI Potential - Newser
Sionna Therapeutics to Participate in Upcoming September Investor Conferences - The Manila Times
CF Drug Developer Sionna Therapeutics to Present at Major September Healthcare Conferences in NYC - Stock Titan
Sionna Therapeutics to Participate in Upcoming September Investor Conferences - GlobeNewswire Inc.
When is the best time to exit Sionna Therapeutics Inc.Gold Moves & Real-Time Price Movement Reports - Newser
Will earnings trigger a reversal in Sionna Therapeutics Inc.2025 Biggest Moves & Low Risk High Win Rate Picks - Newser
What machine learning models say about Sionna Therapeutics Inc.Weekly Trend Summary & Entry Point Confirmation Signals - Newser
Sionna Therapeutics Inc. stock prediction for this weekIndex Update & Weekly Breakout Stock Alerts - Newser
Trend analysis for Sionna Therapeutics Inc. this weekBull Run & Consistent Return Strategy Ideas - Newser
Study testing combination of CFTR modulators begins dosing volunteers - Cystic Fibrosis News Today
Sentiment analysis tools applied to Sionna Therapeutics Inc.July 2025 Institutional & Verified Short-Term Plans - Newser
Sionna Therapeutics Announces First Subjects Dosed in Phase 1 Trial Evaluating NBD1 Stabilizer, SION-451, in Proprietary Dual Combinations in Development for the Treatment of Cystic Fibrosis - MarketScreener
Sionna Therapeutics begins phase 1 trial of CF dual combinations By Investing.com - Investing.com Canada
Sionna Therapeutics Announces First Subjects Dosed in Phase - GlobeNewswire
First-Ever NBD1 Stabilizer: Sionna's Groundbreaking CF Treatment Enters Clinical Testing for 100K Patients - Stock Titan
Sionna Therapeutics Inc. Volume Confirms Breakout — Analysts BullishJuly 2025 Movers & Safe Capital Growth Trade Ideas - Newser
What’s next for Sionna Therapeutics Inc. stock priceQuarterly Profit Summary & Precise Buy Zone Identification - Newser
Sionna Therapeutics Inc (SION) 재무 분석
Sionna Therapeutics Inc (SION)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.98%
8.06%
자본화:
|
볼륨(24시간):